Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Portenoy

Showing results (141-150 of 354) with videos related to

Pageof 36
Sort By:
Schmerz (Berlin, Germany)|June 1, 1990
[The estimation of the i.m. morphine-equivalent in cancer pain treatment with different opioids or different routes of administrations. Practical meaning and limitations.]J Jage, R K Portenoy, K M Foley
Journal of Pain and Symptom Management|February 24, 2001
Unwillingness to fill opioid analgesic prescriptions by local pharmaciesK S Kim, M Glajchen, R K Portenoy
Journal of Pain and Symptom Management|September 9, 2009
Opioid rotation: the science and the limitations of the equianalgesic dose tableHelena Knotkova, Perry G Fine, Russell K Portenoy
Archives of Neurology|September 1, 1983
Increased intracranial pressure with normal ventricular size due to superior vena cava obstructionR K Portenoy, C J Abissi, J B Robbins
The Journal of Pain|November 19, 2003
A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough painBarry V Fortner, Theodore A Okon, Russell K Portenoy
The Journal of Pain|September 1, 2004
Population-based survey of pain in the United States: differences among white, African American, and Hispanic subjectsRussell K Portenoy, Carlos Ugarte, Ivonne Fuller, et al.
The Clinical Journal of Pain|October 24, 2006
A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancerRussell K Portenoy, Donald Taylor, John Messina, et al.
Oncology (Williston Park, N.Y.)|May 23, 1998
Substance abuse issues in cancer patients. Part 2: Evaluation and treatmentS D Passik, R K Portenoy, P L Ricketts
Oncology (Williston Park, N.Y.)|May 12, 1998
Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosisS D Passik, R K Portenoy, P L Ricketts
Neurology|January 1, 1987
Back pain in the cancer patient: an algorithm for evaluation and managementR K Portenoy, R B Lipton, K M Foley
Pageof 36

Showing results (141-150 of 354) with videos related to

Sort By:
Pageof 36
Schmerz (Berlin, Germany)|June 1, 1990
[The estimation of the i.m. morphine-equivalent in cancer pain treatment with different opioids or different routes of administrations. Practical meaning and limitations.]J Jage, R K Portenoy, K M Foley
Journal of Pain and Symptom Management|February 24, 2001
Unwillingness to fill opioid analgesic prescriptions by local pharmaciesK S Kim, M Glajchen, R K Portenoy
Journal of Pain and Symptom Management|September 9, 2009
Opioid rotation: the science and the limitations of the equianalgesic dose tableHelena Knotkova, Perry G Fine, Russell K Portenoy
Archives of Neurology|September 1, 1983
Increased intracranial pressure with normal ventricular size due to superior vena cava obstructionR K Portenoy, C J Abissi, J B Robbins
The Journal of Pain|November 19, 2003
A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough painBarry V Fortner, Theodore A Okon, Russell K Portenoy
The Journal of Pain|September 1, 2004
Population-based survey of pain in the United States: differences among white, African American, and Hispanic subjectsRussell K Portenoy, Carlos Ugarte, Ivonne Fuller, et al.
The Clinical Journal of Pain|October 24, 2006
A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancerRussell K Portenoy, Donald Taylor, John Messina, et al.
Oncology (Williston Park, N.Y.)|May 23, 1998
Substance abuse issues in cancer patients. Part 2: Evaluation and treatmentS D Passik, R K Portenoy, P L Ricketts
Oncology (Williston Park, N.Y.)|May 12, 1998
Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosisS D Passik, R K Portenoy, P L Ricketts
Neurology|January 1, 1987
Back pain in the cancer patient: an algorithm for evaluation and managementR K Portenoy, R B Lipton, K M Foley
Pageof 36